WuXi Bio boosts share sale size to $599m

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

WuXi Bio boosts share sale size to $599m

Jonathan Breen
April 01, 2020 09:00 AM
Allergen_Pills_Pharma_23May2017_Fotolia_230x150

WuXi Biologics Holdings has pocketed HK$4.6bn ($599m) after selling part of its stake in subsidiary WuXi Biologics (Cayman).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Health and BiotechEquityChinaHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificABBs-Block TradesEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article